OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies
Sabine Haggenburg, Quincy Hofsink, Caroline E. Rutten, et al.
Seminars in Hematology (2022) Vol. 59, Iss. 4, pp. 192-197
Open Access | Times Cited: 8
Sabine Haggenburg, Quincy Hofsink, Caroline E. Rutten, et al.
Seminars in Hematology (2022) Vol. 59, Iss. 4, pp. 192-197
Open Access | Times Cited: 8
Showing 8 citing articles:
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg‐Witte, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102040-102040
Open Access | Times Cited: 12
Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg‐Witte, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102040-102040
Open Access | Times Cited: 12
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
Anne M. Spanjaart, Per Ljungman, Gloria Tridello, et al.
Leukemia (2024) Vol. 38, Iss. 9, pp. 1985-1991
Open Access | Times Cited: 4
Anne M. Spanjaart, Per Ljungman, Gloria Tridello, et al.
Leukemia (2024) Vol. 38, Iss. 9, pp. 1985-1991
Open Access | Times Cited: 4
Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients
K. L. Juliëtte Schmidt, Noël Dautzenberg, Peter M. Hoogerbrugge, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2562-2562
Open Access | Times Cited: 10
K. L. Juliëtte Schmidt, Noël Dautzenberg, Peter M. Hoogerbrugge, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2562-2562
Open Access | Times Cited: 10
Increase in antibody titer and change over time associated with severe acute respiratory syndrome coronavirus 2 infection after mRNA vaccination: Consideration of the significance of additional vaccination
Hiroshi Kusunoki, Michiko Ohkusa, Rie Iida, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 3
Hiroshi Kusunoki, Michiko Ohkusa, Rie Iida, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 3
Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study
Makoto Saito, Akio Mori, Takashi Ishio, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 328-328
Open Access | Times Cited: 2
Makoto Saito, Akio Mori, Takashi Ishio, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 328-328
Open Access | Times Cited: 2
Новая коронавирусная инфекция COVID-19 и состояние гуморального иммунного ответа у пациентов с гематологическими злокачественными опухолями
Е.В. Игнатьева, О. А. Рукавицын, С. П. Казаков
Clinical oncohematology (2024) Vol. 17, Iss. 4, pp. 415-421
Open Access
Е.В. Игнатьева, О. А. Рукавицын, С. П. Казаков
Clinical oncohematology (2024) Vol. 17, Iss. 4, pp. 415-421
Open Access
Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies
Adrian Wiestner
Seminars in Hematology (2022) Vol. 59, Iss. 4, pp. 175-176
Open Access
Adrian Wiestner
Seminars in Hematology (2022) Vol. 59, Iss. 4, pp. 175-176
Open Access
